Cobra Biologics is a leading international contract development and manufacturing organisation (CDMO) supporting the global life sciences industry in the development and manufacture of proteins, DNA, viral vectors and microbiota for pre-clinical through to clinical and commercial supply.
Cobra has a 20 years track record in producing biologics and pharmaceuticals which has given our people a unique knowledge base as both manufacturer and service providers for the global life sciences market.
Cobra has two GMP approved facilities in Sweden and the UK, each with specific expertise tailored to serving our customers around the world. We offer a broad range of integrated and stand-alone contract development and manufacturing services, bespoke to individual customer requirements, stretching from process development to the supply of investigational medicinal product.
As a trusted provider and a key partner in the drug development and commercialisation process, Cobra takes pride in manufacturing excellence, delivering what we promise and helping our customers to develop drugs for the benefit of patients.